2211 — Universal Health International Holding Income Statement
0.000.00%
- HK$193.46m
- HK$206.13m
- CNY711.51m
- 16
- 68
- 47
- 38
Annual income statement for Universal Health International Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,185 | 1,274 | 1,297 | 1,089 | 712 |
Cost of Revenue | |||||
Gross Profit | 157 | 204 | 214 | 180 | 113 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,849 | 1,462 | 1,395 | 1,089 | 737 |
Operating Profit | -663 | -189 | -98.4 | 0.082 | -25.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -671 | -188 | -112 | -2.79 | -22.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -676 | -188 | -106 | 0.58 | -25.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -675 | -188 | -105 | 0.413 | -26 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -675 | -188 | -105 | 0.413 | -26 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -13.8 | -3.82 | -1.67 | -0.227 | -0.269 |